What check size does David Shin write?

David Shin typically writes checks of $100K – $5M.

Where did David Shin go to school?

David Shin studied at The Bridge | Digital Talent Accelerator (Bootcamp in Data Science | Artificial intelligence | Machine Learning); Universidad Autónoma de Madrid (PhD in Molecular Biosciences (Neuroscience), Research); Universidad Autónoma de Madrid (Master in Molecular Biomedicine).

David Shin

Investor

Scientific Fellow Strategic Partnering at Debiopharm Innovation Fund · Investor at Dash Fund

New York City

Writes $100K – $5M checks · typically $1.5M

Find your path to David

191 people in our graph can introduce you to David.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Sara Picó to introduce you to David

You →Sara · together at cicCartuja (2013–2015) →David

Ask Jamie Chen to introduce you to David

You →Jamie · 2 people · together at Barcelona Activa →David

Ask Sam Okafor to introduce you to David

You →Sam · 3 people · together at Centro de Biología Molecular Severo Ochoa, CBMSO →David

Your email: the people you already email who know David
2nd- and 3rd-degree connections: people you know who worked, studied or invested with David
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

David Shin is a Scientific Fellow, Strategic Partnering at Debiopharm, working in search and evaluation within oncology. He holds a PhD in neurosciences and has over ten years of experience spanning basic and translational research, data science, and venture capital, with a background in neuroscience and aging as well as investment analysis and strategic planning.

Experience

DebiopharmScientific Fellow Strategic Partneringcurrent2025 — presentLausanne, Vaud, Switzerland
Barcelona ActivaStartup Mentor2025
PIPRABusiness Development2025Zurich, Switzerland
DebiopharmVenture Capital Analyst Intern2024 — 2025Lausanne, Vaud, Switzerland
University of Lausanne - UNILAging Postdoctoral researcher2022 — 2024Lausanne, Vaud, Switzerland
Centro de Biología Molecular Severo Ochoa, CBMSONeuroscience researcher (PhD)2017 — 2022Madrid, Community of Madrid, Spain
Centro de Biología Molecular Severo Ochoa, CBMSOResearch Associate2015 — 2017Madrid, Community of Madrid, Spain
cicCartujaResearch Associate2013 — 2015Seville, Andalusia, Spain

Skills & more

RoedoresStart-up VenturesProject ManagementBusiness StrategyMarket Research1Business Development1Start-up Support1Scientific BackgroundMentoringProject TeamsStudy ReportsProject Plans

+12 more

Project LeadershipExternal RelationshipsLiteratureCompetitive IntelligenceInversionesLaboratory SkillsSocial Media CommunicationsPandas (Software)Data AnalysisInglésEspañolLiterature Reviews

Languages English · French · Italian · Spanish

Introduction to Drug Hunting — Novartis
Foundations of Project Management — Google
Private Equity and Venture Capital — Università Bocconi
MLOps — Canvas Credentials (Badgr)
TensorFlow & Keras — Canvas Credentials (Badgr)
SQL — Canvas Credentials (Badgr)
Maths for Data Science — Canvas Credentials (Badgr)
Deep Learning — Canvas Credentials (Badgr)
Machine Learning Engineer — Canvas Credentials (Badgr)
Data Wrangling — Canvas Credentials (Badgr)

From David's professional profile.

Colleagues at Debiopharm Innovation Fund

Angela Zubel

Chief Development Officer, Research & Development at Debiopharm Innovation Fund

Bertrand Ducrey

Chief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm at Debiopharm Innovation Fund

Cedric Odje

Investment Associate at Debiopharm Innovation Fund

Chris Thomas

Director, Investments at Wollemi Capital

Dawid Książczak

Chief Legal Officer at McWin Capital Partners

Frédéric Lévy

Chief Scientific Officer, Search & Evaluation and Scientific Innovation at Debiopharm Innovation Fund

Kavita Patel

Principal at Muus Climate Partners

Kerstin Planitzer-Zipf

Chief Compliance Officer at Cipio Partners

Frequently asked questions

Who is David Shin?: David Shin is a Scientific Fellow, Strategic Partnering at Debiopharm, working in search and evaluation within oncology. He holds a PhD in neurosciences and has over ten years of experience spanning basic and translational research, data science, and venture capital, with a background in neuroscience and aging as well as investment analysis and strategic planning.
Where does David Shin work?: David Shin is Scientific Fellow Strategic Partnering at Debiopharm Innovation Fund.
What check size does David Shin write?: David Shin typically writes checks of $100K – $5M.
Where did David Shin go to school?: David Shin studied at The Bridge | Digital Talent Accelerator (Bootcamp in Data Science | Artificial intelligence | Machine Learning); Universidad Autónoma de Madrid (PhD in Molecular Biosciences (Neuroscience), Research); Universidad Autónoma de Madrid (Master in Molecular Biomedicine).